PON2 and lung adenocarcinoma: Raised PON2 levels in human lung adenocarcinoma cells, particularly altered cell cycle progression and metabolism, revealing a steady decline of PON2 in Lewis Lung Carcinoma cells through RNA interference (Whitt et al. 2023).